Data protection Impressum

Newsroom

EP Equity Investment (EPEI), a company dedicated to investing in promising European companies, has acquired a 24.99% stake in Nanobacterie to advance the development of innovative treatments for prostate cancer.

Nanobacterie secures strategic investment from EP Equity to advance prostate cancer treatment

6 May 2024

Trufflepig Forensics GmbH, a Bavarian-founded ethical hacking firm, has announced the establishment of its new subsidiary, Trufflepig IT-Forensics Suisse, in Fribourg.

Trufflepig Forensics expands to Fribourg to strengthen cybersecurity in the DACH region

6 May 2024

The Swiss Battery Technology Center has launched the LAMBDA project to train robots for safe, efficient battery recycling using AI.

Swiss Battery Technology Center innovates with robotic battery recycling

6 May 2024

MTTA, a new watchmaking hub, will open in Le Locle by 2028 to foster innovation and collaboration in the industry.

Le Locle will be home to the new MTTA watchmaking center of excellence by 2028

6 May 2024

The Innovation Office of the University of Bern empowers the academic and clinical community to turn groundbreaking ideas into societal and economic value.

Making ideas fly at the University of Bern’s Innovation Office

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (April 2024)

30 April 2024

NovaMea, a cleantech start-up from the EPFL, has raised USD 3.2 million to advance the research and development of its green hydrogen production technology.

NovaMea secures USD 3.2 million to boost green hydrogen production

30 April 2024

In the canton of Valais, the BlueArk Challenge continues to be a catalyst for innovation in water management, as demonstrated in its latest round where two cutting-edge projects each secured CHF 10,000 in funding.

The BlueArk Challenge rewards two breakthrough technologies for advanced water management

30 April 2024

Takeda Pharmaceutical has announced a CHF 5 million investment in renewable energy for its Neuchâtel facility.

Takeda commits CHF 5 million to renewable energy for its Neuchâtel site

29 April 2024

Risklick, a spin-off from the University of Bern, has unveiled its cutting-edge software, Protocol AI, designed to transform the landscape of pharmaceutical development.

UniBe spin-off Risklick unveils AI tool to streamline clinical trials

29 April 2024

1 … 38 39 40 41 42 43 44 45 46 … 149